We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
CNO Financial Group
CNO
$5.16B
| $10.9M | 0.03% |
460,501
+203,415
| +79% | +$4.53M |
|
527
Itron
ITRI
$4.04B
| $10.9M | 0.03% |
150,902
-144,625
| -49% | -$9.15M |
|
528
Abercrombie & Fitch
ANF
$5.74B
| $10.9M | 0.03% |
288,451
-413
| -0.1% | -$11.8K |
|
529
Annexon
ANNX
$743M
| $10.8M | 0.03% |
3,057,800
| – | – |
|
530
Palomar
PLMR
$3.64B
| $10.7M | 0.03% |
184,372
-8,881
| -5% | -$475K |
|
531
Generac Holdings
GNRC
$10.3B
| $10.5M | 0.03% |
70,200
+33,584
| +92% | +$3.83M |
|
532
Fiverr
FVRR
$326M
| $10.4M | 0.03% |
400,000
+190,000
| +90% | +$5.73M |
|
533
Domo
DOMO
$184M
| $10.3M | 0.03% |
700,000
| – | – |
|
534
Coca-Cola Femsa
KOF
$23.4B
| $10.2M | 0.03% |
122,901
-26,242
| -18% | -$2.25M |
|
535
Warrior Met Coal
HCC
$4.84B
| $10.2M | 0.03% |
262,530
+319
| +0.1% | +$11.6K |
|
536
WillScot Mobile Mini Holdings
WSC
$3.27B
| $10.1M | 0.03% |
212,098
+865
| +0.4% | +$38.7K |
|
537
California Resources
CRC
$5.12B
| $10.1M | 0.03% |
+222,384
| New | +$9.02M |
|
538
Pinnacle West Capital
PNW
$11.5B
| $9.97M | 0.02% |
122,368
-4,904
| -4% | -$391K |
|
|
NEWR
539
DELISTED
New Relic, Inc.
NEWR
| $9.96M | 0.02% |
152,144
-11,844
| -7% | -$854K |
|
540
Boston Scientific
BSX
$63.6B
| $9.94M | 0.02% |
183,704
+20,310
| +12% | +$1.06M |
|
541
Kirby Corp
KEX
$7.34B
| $9.93M | 0.02% |
129,036
-2,628
| -2% | -$189K |
|
542
Minerva Neurosciences
NERV
$183M
| $9.9M | 0.02% |
1,351,275
+150,000
| +12% | +$792K |
|
543
Jackson Financial
JXN
$9.36B
| $9.89M | 0.02% |
323,220
-67,996
| -17% | -$2.19M |
|
544
SAP
SAP
$249B
| $9.83M | 0.02% |
71,850
+37,780
| +111% | +$5M |
|
545
Cinemark Holdings
CNK
$3.93B
| $9.79M | 0.02% |
+593,481
| New | +$9.86M |
|
546
Tactile Systems Technology
TCMD
$510M
| $9.77M | 0.02% |
391,961
-10,453
| -3% | -$217K |
|
547
Equinix
EQIX
$99.4B
| $9.7M | 0.02% |
12,371
+6,829
| +123% | +$5M |
|
|
ONTF
548
DELISTED
ON24
ONTF
| $9.54M | 0.02% |
1,175,414
-79,072
| -6% | -$657K |
|
549
Goodyear
GT
$1.51B
| $9.53M | 0.02% |
696,534
-8,350
| -1% | -$104K |
|
550
Cal-Maine
CALM
$3.47B
| $9.52M | 0.02% |
211,608
+1,703
| +0.8% | +$84.6K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.